Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
STEP 2: outcomes in type 2 diabetes STEP 2 specifically studied semaglutide in 1,210 adults with type 2 diabetes and overweight or obesity
The most important surprise may be that the medications themselves are only part of the story
The three trials summarized below illustrate the program's range of comparators: placebo, an active injectable comparator, and a basal insulin analogue
Convenient dosing: The pre-filled pen allows easy once-weekly self-administration
Patients should also be cautious about products sold online, since unverified weight-loss injections may not contain what they claim
US$ 27.28
US$ 29.00
US$ 25.95
US$ 26.21
